HomeNDC LookupRxCUI directory › RxCUI 1190433

Glycerin 1037 MG/ML Enema [Pedia-Lax Liquid Glycerin Suppositories] — RxCUI 1190433

RxNorm drug concept · Semantic branded drug
RxCUI 1190433 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1190433
Official nameGlycerin 1037 MG/ML Enema [Pedia-Lax Liquid Glycerin Suppositories]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPedia-Lax Liquid Glycerin Suppositories 2.8 GM per 2.7 ML Enema; Pedia-Lax Liquid Glycerin Suppositories 2.8 GM in 2.7 mL Enema
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,664 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Glycerin 1037 MG/ML Enema [Pedia-Lax Liquid Glyc... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glycerin 1037 MG/ML Enema [Pedia-Lax Liquid Glycerin Suppositories] RxCUI 1190433

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glycerin 4910
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pedia-Lax Liquid Glycerin Suppositories 1190429
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glycerin Enema 440295
    • Glycerin Rectal Product 1156856
    • Glycerin Enema [Pedia-Lax Liquid Glycerin Suppositories] 1795145
    • Pedia-Lax Liquid Glycerin Suppositories Rectal Product 1190432
    • Enema 317678
    • Rectal Product 1151127
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Glycerin 1037 MG/ML Enema 895966
    • Glycerin 1037 MG/ML 895965
    • Glycerin 1037 MG/ML [Pedia-Lax Liquid Glycerin Suppositories] 2117242

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glycerin 1037 MG/ML Enema SCD · 895966
  • Glycerin 1037 MG/ML SCDC · 895965
  • Glycerin Enema SCDF · 440295
  • Glycerin Rectal Product SCDG · 1156856

Brand-Name Concepts

  • Glycerin 1037 MG/ML [Pedia-Lax Liquid Glycerin Suppositories] SBDC · 2117242
  • Glycerin Enema [Pedia-Lax Liquid Glycerin Suppositories] SBDF · 1795145
  • Pedia-Lax Liquid Glycerin Suppositories Rectal Product SBDG · 1190432
  • Pedia-Lax Liquid Glycerin Suppositories BN · 1190429

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1190433 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00132-0190-12 6 APPLICATOR in 1 CARTON (0132-0190-12) / 4 mL in 1 APPLICA... Pedia-Lax C.B. Fleet Company, Inc. 2008-03-01
00132-0195-12 6 APPLICATOR in 1 CARTON (0132-0195-12) / 4 mL in 1 APPLICA... Pedia-Lax C.B. Fleet Company, Inc. 2019-02-01
Observed labelers: C.B. Fleet Company, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.